These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8556246

  • 21. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H, Kiki I, Ozbek A, Erdem F, Ayyildiz A.
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [Abstract] [Full Text] [Related]

  • 22. [Seroprevalence of human parvovirus B19 in children with fever and rash in the North of Tunisia].
    Bouafsoun A, Hannachi N, Smaoui H, Boubaker SH, Kazdaghli K, Laabidi D, Boukadida J, Kechrid A.
    Bull Soc Pathol Exot; 2016 Aug; 109(3):165-71. PubMed ID: 27385036
    [Abstract] [Full Text] [Related]

  • 23. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
    Mata Rebón M, Bartolomé Husson C, Bernárdez Hermida I.
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
    [Abstract] [Full Text] [Related]

  • 24. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
    Mauser-Bunschoten EP, Zaaijer HL, van Drimmelen AA, de Vries S, Roosendaal G, van den Berg HM, Lelie PN.
    Vox Sang; 1998 Jan; 74(4):225-7. PubMed ID: 9691402
    [Abstract] [Full Text] [Related]

  • 25. Parvovirus B19 antibodies in patients with haemophilia A.
    Peerlinck K, Goubau P, Reybrouck R, Desmyter J, Vermylen J.
    Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
    [No Abstract] [Full Text] [Related]

  • 26. Population-based study on the seroprevalence of parvovirus B19 in Amsterdam.
    van Rijckevorsel GG, Sonder GJ, Schim van der Loeff MF, van den Hoek JA.
    J Med Virol; 2009 Jul; 81(7):1305-9. PubMed ID: 19475607
    [Abstract] [Full Text] [Related]

  • 27. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B, Larrañaga C, León O, Díaz P, Miranda M, Barría M, Gaggero A.
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of antibodies to parvovirus B 19 in Thailand.
    Poovorawan Y, Theamboonlers A, Suandork P, Hirsch P.
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):422-4. PubMed ID: 11127352
    [Abstract] [Full Text] [Related]

  • 29. Low prevalence of antibody to human parvovirus B19 in Singapore.
    Matsunaga Y, Goh KT, Utagawa E, Muroi N.
    Epidemiol Infect; 1994 Dec; 113(3):537-40. PubMed ID: 7995362
    [Abstract] [Full Text] [Related]

  • 30. [Parvovirus B19 infection in patients with congenital blood coagulation disorders].
    Aguilar Franco C, Lucía Cuesta JF, Ferrer Torres J, Omeñaca Teres M.
    Med Clin (Barc); 1997 May 03; 108(17):641-6. PubMed ID: 9312580
    [Abstract] [Full Text] [Related]

  • 31. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
    van Gessel PH, Gaytant MA, Vossen AC, Galama JM, Ursem NT, Steegers EA, Wildschut HI.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 03; 128(1-2):46-9. PubMed ID: 16406220
    [Abstract] [Full Text] [Related]

  • 32. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A, Addo-Yobo E, Owusu-Ofori S, Akpene H, Sarkodie F, Allain JP.
    Transfusion; 2006 Sep 03; 46(9):1593-600. PubMed ID: 16965589
    [Abstract] [Full Text] [Related]

  • 33. Parvovirus B19 and immune disorders.
    Pugliese A, Beltramo T, Torre D, Roccatello D.
    Cell Biochem Funct; 2007 Sep 03; 25(6):639-41. PubMed ID: 16917962
    [Abstract] [Full Text] [Related]

  • 34. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F, Khelifa R, Zouari R, Kchir M, Karoui M, Essid R.
    Arch Inst Pasteur Tunis; 2003 Sep 03; 80(1-4):9-15. PubMed ID: 15941063
    [Abstract] [Full Text] [Related]

  • 35. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W, Halim MA, Al-Nakib W.
    Virology; 2009 Jul 20; 390(1):56-63. PubMed ID: 19450862
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Seroprevalence of human parvovirus B19 in ambulatory population of Cantabria, northern Spain].
    Ruiz de Alegría Puig C, Balbás García de Bustos R, Herrera González MC, Martínez-Bernal MA.
    An Pediatr (Barc); 2009 Nov 20; 71(5):475-6. PubMed ID: 19783492
    [No Abstract] [Full Text] [Related]

  • 38. Detection of IgE anti-parvovirus antibodies in human breast milk.
    Smith-Norowitz TA, Drew H, Norowitz HM, Nowakowski M, Bluth EF, Durkin HG, Bluth MH.
    Ann Clin Lab Sci; 2008 Nov 20; 38(2):168-73. PubMed ID: 18469364
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity.
    Gross O, Tschernatsch M, Bräu ME, Hempelmann G, Birklein F, Kaps M, Madlener K, Blaes F.
    Eur J Pain; 2007 Feb 20; 11(2):237-40. PubMed ID: 16545972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.